Experiences with

Rydapt

1 public post

AML patients in Australia today learn midostaurin (Rydapt®) will be available under new PBS listing. Press Release below.

media queries, please contact media@leukaemia.org.au New PBS listing vital to Australians living with Acute Myeloid Leukaemia (AML) Leukaemia Foundation CEO Mr Bill Petch has today supported the Health Minister Mr Greg Hunt’s Pharmaceuticals Benefits Scheme (PBS) listing announcement of midostaurin (Rydapt
Hidden profile image
Hidden
in MPN Voice
Want to take advantage of all our features? Just log in!
or
    Filter results
    Posted in
    Sort by